We are live on ! Find out more
LSTA icon

Lisata Therapeutics

28 hedge funds and large institutions have $2.15M invested in Lisata Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

22% less capital invested

Capital invested by funds: $2.76M → $2.15M (-$612K)

35% less funds holding

Funds holding: 4328 (-15)

79% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 19

Holders
28
Holders Change
-15
Holders Change %
-34.88%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
5
Closed
19
Calls
Puts
Net Calls
Net Calls Change

LSTA Hedge Fund Activity: Q3 2016 in Review

28 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q3 2016, worth a combined $2.15M — down 22% from $2.76M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of LSTA and 4 opened new positions — a net loss of 15 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Pine River Capital Management, adding an estimated $5.97M. The largest seller was Great Point Partners, exiting entirely with an estimated $900K sold.

  • 28 institutional investors held Lisata Therapeutics (LSTA) as of Q3 2016, down from 43 in Q2 2016.
  • Funds reported $2.15M of Lisata Therapeutics stock for Q3 2016, down 22% quarter-over-quarter.
  • 4 funds opened new Lisata Therapeutics positions in Q3 2016 and 19 closed out, a net change of -15 holders.
  • The largest Lisata Therapeutics buyer in Q3 2016 was Pine River Capital Management, an estimated $5.97M added.
  • The largest Lisata Therapeutics seller in Q3 2016 was Great Point Partners, an estimated $900K sold.

Based on aggregated 13F filings for Q3 2016.